The Comparative Safety and Effectiveness of Bivalirudin Versus Heparin Monotherapy in Patients on Dialysis Undergoing Percutaneous Coronary Intervention: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)

BACKGROUND: Dialysis patients are at a higher risk of bleeding after PCI; however, due to their exclusion from randomized clinical trials, the optimal antithrombotic regimen for this population remains unknown. We sought to evaluate the comparative safety and effectiveness of bivalirudin monotherapy...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Catheter Cardiovasc Interv
Autori principali: Sukul, Devraj, Seth, Milan, Schreiber, Theodore, Khandelwal, Akshay, Cannon, Louis A., LaLonde, Thomas A., Gurm, Hitinder S.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2017
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6850212/
https://ncbi.nlm.nih.gov/pubmed/28303632
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccd.27001
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi